Page 97 - Cronos Group News Today

/CBD Testing Market with Covid-19 Impact Analysis | also Industry is Booming Worldwide|| Future Plans and Industry Growth with High CAGR by Forecast 2028 | COVID-19 Impact|| CBD Testing Market with Covid-19 Impact Analysis | also Industry is Booming Worldwide|| Future Plans and Industry Growth with High CAGR by Forecast 2028 | COVID-19 Impact|| The market for cannabidiol (CBD) testing is projected to rise at a rate of 20.00% in the 2021 to 2028 forecast period. 14 To thrive in this rapidly tr...

February 14, 2021 at 10:56 am You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Friends, We can’t say we are surprised by what’s going on, as we first explained in October why the Canadian cannabis operators would benefit from perceived opportunities in ...

Cisco and two other companies pay high yields and trade at discount valuations.

TORONTO — Canada's main stock index fell for the first time in February as frenzied buying in the cannabis sector strongly reversed course. The S&P/TSX composite index slipped for the first time in nine sessions and closed down 64.

Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar cannabis boom.

By Reuters Staff (Updates prices, adds sector details) Feb 12 (Reuters) - Canada’s main stock index inched lower on Friday, dragged down by stocks of cannabis companies and a dismal wholesale trade data, while further losses were capped by strength in financial stocks. * The healthcare sector shed 1.7%, as cannabis companies including Aphria Inc, Cronos Group, and Hexo Corp fell over 1% in early trade. * Statistics Canada data showed that the domestic wholesale trade fell by 1.3% in December ...

Newell Brands’ revenue climbs by 2.5% in the fiscal fourth quarter. Newell Brands forecasts up to £1.19 of full-year adjusted EPS.

With yields ranging from 4.1% to 10.5%, these high-quality companies won't cause income investors to lose sleep.

buprenorphine (Pixabay) Marijuana Policy Major Marijuana Coalition Forms to Coordinate Legalization Push, But Some Key Advocacy Players Are Not Involved. A bunch of industry and advocacy groups have formed a new coalition, the United States Cannabis Council, to press forward on marijuana legalization. But while the group is headed by Marijuana Policy Project executive director Steven Hawkins on an interim basis, it does not include major advocacy groups such as NORML and the Drug Policy Allianc...

Good news for the cannabis industry is standing out on a calm market day.